Paeonol exerts anti‑tumor activity against colorectal cancer cells by inducing G0/G1 phase arrest and cell apoptosis via inhibiting the Wnt/β‑catenin signaling pathway

Liu,Li‑Hua; Shi,Ren‑Jie; Chen,Zhi‑Cheng

doi:10.3892/ijmm.2020.4629

Paeonol exerts anti‑tumor activity against colorectal cancer cells by inducing G0/G1 phase arrest and cell apoptosis via inhibiting the Wnt/β‑catenin signaling pathway

Authors:
- Li‑Hua Liu
- Ren‑Jie Shi
- Zhi‑Cheng Chen
View Affiliations

Affiliations: No. 1 Clinical Medical College, Nanjing University of Chinese Medicine, Nanjing, Jiangsu 210029, P.R. China, Department of Anorectal Surgery, Zhongda Hospital Affiliated to Southeast University, Nanjing, Jiangsu 210009, P.R. China
Published online on: June 4, 2020 https://doi.org/10.3892/ijmm.2020.4629
Pages: 675-684
Copyright: © Liu et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Paeonol is a simple phenolic compound isolated from herbal root bark, which has been reported to possess numerous biological and pharmacological characteristics, including a desirable anti‑tumor effect. To date, the effect of paeonol against colorectal cancer (CRC) cells is yet to be fully elucidated. Therefore, the present study aimed to identify the underlying mechanism via which paeonol exerts its anti‑tumor activity on HCT116 cells. After incubation with various concentrations of paeonol (7.8125, 15.625, 31.25, 62.5, 125, 250 and 500 µg/ml), the inhibitory effect of paeonol on cell viability was assessed using a Cell Counting Kit‑8 assay. Cell apoptosis and cell cycle distribution were measured using flow cytometry. Moreover, caspase activity was measured using a colorimetric caspase assay. Luciferase assay was also used to determine the β‑catenin‑mediated transcriptional activity of T‑cell specific transcription factor/lymphoid‑enhancer binding factor (TCF/LEF), and western blotting analysis was performed to measure the related expression of proteins. The results indicated that paeonol exhibited a notable effect against HCT116 cells by inducing G0/G1‑phase arrest, as demonstrated by downregulation of the cell cycle regulators cyclin‑dependent kinase 4 and cyclin D1 and upregulation of p21Cip1 in a dose‑dependent manner. Furthermore, paeonol dose‑dependently induced cell apoptosis, accompanied by an increase in the Bax/Bcl‑2 ratio, release of cytochrome c and further activation of caspases. Paeonol also dose‑dependently blocked the activation of the Wnt/β‑catenin signaling pathway by suppressing the expression of β‑catenin, resulting in a decrease in β‑catenin‑mediated activity of TCF/LEF and downregulation of downstream target genes, including cyclin D1, survivin and c‑Myc. Therefore, the present results suggested that paeonol exerted its anti‑tumor effects on CRC cells, including the inhibition of cell proliferation, induction of cell cycle arrest and initiation of apoptosis, at least partly by suppressing the Wnt/β‑catenin pathway, which may offer a promising therapeutic strategy for CRC.

View Figures

View References

1	Nguyen MN, Choi TG, Nguyen DT, Kim JH, Jo YH, Shahid M, Akter S, Aryal SN, Yoo JY, Ahn YJ, et al: CRC-113 gene expression signature for predicting prognosis in patients with colorectal cancer. Oncotarget. 6:31674–31692. 2015. View Article : Google Scholar : PubMed/NCBI
2	Feng RM, Zong YN, Cao SM and Xu RH: Current cancer situation in China: Good or bad news from the 2018 global cancer statistics? Cancer Commun (Lond). 39:222019. View Article : Google Scholar
3	Li L and Ma BB: Colorectal cancer in Chinese patients: Current and emerging treatment options. Onco Targets Ther. 7:1817–1828. 2014.PubMed/NCBI
4	Wang P, Gao XY, Yang SQ, Sun ZX, Dian LL, Qasim M, Phyo AT, Liang ZS and Sun YF: Jatrorrhizine inhibits colorectal carcinoma proliferation and metastasis through Wnt/β-catenin signaling pathway and epithelial-mesenchymal transition. Drug Des Dev Ther. 13:2235–2247. 2019. View Article : Google Scholar
5	Stintzing S: Management of colorectal cancer. F1000Prime Rep. 6:1082014. View Article : Google Scholar
6	Koosha S, Alshawsh MA, Looi CY, Seyedan A and Mohamed Z: An association map on the effect of flavonoids on the signaling pathways in colorectal cancer. Int J Med Sci. 13:374–385. 2016. View Article : Google Scholar : PubMed/NCBI
7	Chen Z, Zhang B, Gao F and Shi R: Modulation of G₂/M cell cycle arrest and apoptosis by luteolin in human colon cancer cells and xenografts. Oncol Lett. 15:1559–1565. 2018.PubMed/NCBI
8	Lou Y, Wang C, Tang Q, Zheng W, Feng Z, Yu X, Guo X and Wang J: Paeonol inhibits IL-1β-induced inflammation via PI3K/Akt/NF-κB pathways: In vivo and vitro studies. Inflammation. 40:1698–1706. 2017. View Article : Google Scholar : PubMed/NCBI
9	Chen B, Ning M and Yang G: Effect of paeonol on antioxidant and immune regulatory activity in hepatocellular carcinoma rats. Molecules. 17:4672–4683. 2012. View Article : Google Scholar : PubMed/NCBI
10	Fu J, Yu LH, Luo J, Huo R and Zhu B: Paeonol induces the apoptosis of the SGC-7901 gastric cancer cell line by downregulating ERBB2 and inhibiting the NF-κB signaling pathway. Inter J Mol Mede. 42:1473–1483. 2018.
11	Saahene RO, Wang J, Wang ML, Agbo E and Pang D: The anti-tumor mechanism of paeonol on CXCL4/CXCR3-B signals in breast cancer through induction of tumor cell apoptosis. Cancer Biother Radiopharm. 33:233–240. 2018. View Article : Google Scholar : PubMed/NCBI
12	Wu J, Xue X, Zhang B, Jiang W, Cao H, Wang R, Sun D and Guo R: The protective effects of paeonol against epirubicin-induced hepatotoxicity in 4T1-tumor bearing mice via inhibition of the PI3K/Akt/NF-kB pathway. Chem Biol Interact. 244:1–8. 2016. View Article : Google Scholar
13	He X, Han W, Hu SX, Zhang MZ, Hua JL and Peng S: Canonical Wnt signaling pathway contributes to the proliferation and survival in porcine pancreatic stem cells (PSCs). Cell Tissue Res. 362:379–388. 2015. View Article : Google Scholar : PubMed/NCBI
14	Liu N, Jiang F, Han XY, Li M, Chen WJ, Liu QC, Liao CX and Lv YF: MiRNA-155 promotes the invasion of colorectal cancer SW-480 cells through regulating the Wnt/β-catenin. Eur Rev Med Pharmacol Sci. 22:101–109. 2018.PubMed/NCBI
15	Lee MA, Kim WK, Park HJ, Kang SS and Lee SK: Anti-proliferative activity of hydnocarpin, a natural lignan, is associated with the suppression of Wnt/β-catenin signaling pathway in colon cancer cells. Bioorg Med Chem Lett. 23:5511–5514. 2013. View Article : Google Scholar : PubMed/NCBI
16	Li T, Zhang L and Huo X: Inhibitory effects of aesculetin on the proliferation of colon cancer cells by the Wnt/β-catenin signaling pathway. Oncol Lett. 15:7118–7122. 2018.PubMed/NCBI
17	Jia Y, Chen L, Guo S and Li Y: Baicalin induced colon cancer cells apoptosis through miR-217/DKK1-mediated inhibition of Wnt signaling pathway. Mol Biol Rep. 46:1693–1700. 2019. View Article : Google Scholar : PubMed/NCBI
18	Li Y, Qin X, Li P, Zhang H, Lin T, Miao Z and Ma S: Isobavachalcone isolated from Psoralea corylifolia inhibits cell proliferation and induces apoptosis via inhibiting the AKT/GSK-3β/β-catenin pathway in colorectal cancer cells. Drug Des Dev Ther. 13:1449–1460. 2019. View Article : Google Scholar
19	Liu MP, Li W, Dai C, Lam CWK, Li Z, Chen JF, Chen ZG, Zhang W and Yao MC: Aqueous extract of Sanguisorba officinalis blocks the Wnt/β-catenin signaling pathway in colorectal cancer cells. RSC Adv. 8:10197–10206. 2018. View Article : Google Scholar
20	He L, Lu N, Dai Q, Zhao Y, Zhao L, Wang H, Li Z, You Q and Guo Q: Wogonin induced G1 cell cycle arrest by regulating Wnt/β-catenin signaling pathway and inactivating CDK8 in human colorectal cancer carcinoma cells. Toxicology. 312:36–47. 2013. View Article : Google Scholar : PubMed/NCBI
21	Lu H, Gao F, Shu G, Xia G, Shao Z, Lu H and Chen K: Wogonin inhibits the proliferation of myelodysplastic syndrome cells through the induction of cell cycle arrest and apoptosis. Mol Med Rep. 12:7285–7292. 2015. View Article : Google Scholar : PubMed/NCBI
22	Xu W and McArthur G: Cell cycle regulation and melanoma. Curr Oncol Rep. 18:342016. View Article : Google Scholar : PubMed/NCBI
23	Tane S, Ikenishi A, Okayama H, Iwamoto N, Nakayama KI and Takeuchi T: CDK inhibitors, p21(Cip1) and p27(Kip1), participate in cell cycle exit of mammalian cardiomyocytes. Biochem and Bioph Res Co. 443:1105–1109. 2014. View Article : Google Scholar
24	Gao N, Flynn DC, Zhang Z, Zhong XS, Walker V, Liu KJ, Shi X and Jiang BH: G1 cell cycle progression and the expression of G1 cyclins are regulated by PI3K/AKT/mTOR/p70S6K1 signaling in human ovarian cancer cells. Am J Physiol Cell Physiol. 287:C281–C291. 2004. View Article : Google Scholar : PubMed/NCBI
25	Akbari A, Amanpour S, Muhammadnejad S, Ghahremani MH, Ghaffari SH, Dehpour AR, Mobini GR, Shidfar F, Abastabar M, Khoshzaban A, et al: Evaluation of antitumor activity of a TGF-beta receptor I inhibitor (SD-208) on human colon adeno-carcinoma. Daru. 22:472014. View Article : Google Scholar
26	Hu H, Wang S, Shi D, Zhong B, Huang X, Shi C and Shao Z: Lycorine exerts antitumor activity against osteosarcoma cells in vitro and in vivo xenograft model through the JAK2/STAT3 pathway. OncoTargets Ther. 12:5377–5388. 2019. View Article : Google Scholar
27	Zhang L, Tao L, Shi T, Zhang F, Sheng X, Cao Y, Zheng S, Wang A, Qian W, Jiang L and Lu Y: Paeonol inhibits B16F10 melanoma metastasis in vitro and in vivo via disrupting proinflammatory cytokines-mediated NF-κB and STAT3 pathways. IUBMB Life. 67:778–788. 2015. View Article : Google Scholar : PubMed/NCBI
28	Xu Y, Zhu JY, Lei ZM, Wan LJ, Zhu XW, Ye F and Tong YY: Anti-proliferative effects of paeonol on human prostate cancer cell lines DU145 and PC-3. J Physiol Biochem. 73:157–165. 2017. View Article : Google Scholar
29	Li M, Tan SY and Wang XF: Paeonol exerts an anticancer effect on human colorectal cancer cells through inhibition of PGE₂ synthesis and COX-2 expression. Oncol Rep. 32:2845–2853. 2014. View Article : Google Scholar : PubMed/NCBI
30	Zhang LH, Xiao PG and Huang Y: Recent progresses in pharmacological and clinical studies of paeonol. Zhongguo Zhong Xi Yi Jie He Za Zhi. 16:187–190. 1996.In Chinese. PubMed/NCBI
31	Yang S, Wang X and Zhong G: Paeonol inhibits the growth of gastric cancer cells via suppressing HULC expression. Int J Clin Exp Med. 9:13900–13908. 2016.
32	Wang S, Wang X, Gao Y, Peng Y, Dong N, Xie Q, Zhang X, Wu Y, Li M and Li J: RN181 is a tumour suppressor in gastric cancer by regulation of the ERK/MAPK-cyclin D1/CDK4 pathway. J Pathol. 248:204–216. 2019. View Article : Google Scholar : PubMed/NCBI
33	Obaya AJ, Mateyak MK and Sedivy JM: Mysterious liaisons: The relationship between c-Myc and the cell cycle. Oncogene. 18:2934–2941. 1999. View Article : Google Scholar : PubMed/NCBI
34	Li Q, Zhang Y, Sun J and Bo Q: Paeonol-mediated apoptosis of hepatocellular carcinoma cells by NF-κB pathway. Oncol Lett. 17:1761–1767. 2019.PubMed/NCBI
35	Qian L, Murakami T, Kimura Y, Takahashi M and Okita K: Saikosaponin A-induced cell death of a human hepatoma cell line (HuH-7): The significance of the 'sub-G1 peak' in a DNA histogram. Pathol Int. 45:207–214. 1995. View Article : Google Scholar : PubMed/NCBI
36	Ghobrial IM, Witzig TE and Adjei AA: Targeting apoptosis pathways in cancer therapy. CA Cancer J Clin. 55:178–194. 2005. View Article : Google Scholar : PubMed/NCBI
37	Boise LH, González-García M, Postema CE, Ding L, Lindsten T, Turka LA, Mao X, Nuñez G and Thompson CB: bcl-x, a bcl-2-related gene that functions as a dominant regulator of apoptotic cell death. Cell. 74:597–608. 1993. View Article : Google Scholar : PubMed/NCBI
38	Jia L, Macey MG, Yin Y, Newland AC and Kelsey SM: Subcellular distribution and redistribution of Bcl-2 family proteins in human leukemia cells undergoing apoptosis. Blood. 93:2353–2359. 1999. View Article : Google Scholar : PubMed/NCBI
39	Ou Y, Li Q, Wang J, Li K and Zhou S: Antitumor and apoptosis induction effects of paeonol on mice bearing EMT6 breast carcinoma. Biomol Ther (Seoul). 22:341–346. 2014. View Article : Google Scholar
40	Li DW, Liu ZQ, Chen W, Yao M and Li GR: Association of glycogen synthase kinase-3β with Parkinson's disease (Review). Mol Med Rep. 9:2043–2050. 2014. View Article : Google Scholar : PubMed/NCBI
41	Shi L, Wu YX, Yu JH, Chen X, Luo XJ and Yin YR: Research of the relationship between β-catenin and c-myc-mediated Wnt pathway and laterally spreading tumors occurrence. Eur Rev Med Pharmacol Sci. 21:252–257. 2017.PubMed/NCBI
42	Chen Y, Jiang T, Shi L and He K: hcrcn81 promotes cell proliferation through Wnt signaling pathway in colorectal cancer. Med Oncol. 33:32016. View Article : Google Scholar
43	Krishnamurthy N and Kurzrock R: Targeting the Wnt/beta-catenin pathway in cancer: Update on effectors and inhibitors. Cancer Treat Rev. 62:50–60. 2018. View Article : Google Scholar
44	Shen Y, Wang Q and Tian Y: Reversal effect of ouabain on multi-drug resistance in esophageal carcinoma EC109/CDDP cells by inhibiting the translocation of Wnt/β-catenin into the nucleus. Tumor Biol. 37:15937–15947. 2016. View Article : Google Scholar
45	Xiao ZD, Han L, Lee H, Zhuang L, Zhang Y, Baddour J, Nagrath D, Wood CG, Gu J, Wu X, et al: Energy stress-induced lncRNA FILNC1 represses c-Myc-mediated energy metabolism and inhibits renal tumor development. Nat Commun. 8:7832017. View Article : Google Scholar : PubMed/NCBI
46	van de Wetering M, Sancho E, Verweij C, de Lau W, Oving I, Hurlstone A, van der Horn K, Batlle E, Coudreuse D, Haramis AP, et al: The beta-catenin/TCF-4 complex imposes a crypt progenitor phenotype on colorectal cancer cells. Cell. 111:241–250. 2002. View Article : Google Scholar : PubMed/NCBI
47	Cai F, Chen P, Chen L, Biskup E, Liu Y, Chen PC, Chang JF, Jiang W, Jing Y, Chen Y, et al: Human RAD6 promotes G1-S transition and cell proliferation through upregulation of cyclin D1 expression. PLoS One. 9:e1137272014. View Article : Google Scholar : PubMed/NCBI
48	Zhang H, Zhang X, Ji S, Hao C, Mu Y, Sun J and Hao J: Sohlh2 inhibits ovarian cancer cell proliferation by upregulation of p21 and downregulation of cyclin D1. Carcinogenesis. 35:1863–1871. 2014. View Article : Google Scholar : PubMed/NCBI
49	Tetsu O and McCormick F: Beta-catenin regulates expression of cyclin D1 in colon carcinoma cells. Nature. 398:422–426. 1999. View Article : Google Scholar : PubMed/NCBI
50	Ho YS, Tsai WH, Lin FC, Huang WP, Lin LC, Wu SM, Liu YR and Chen WP: Cardioprotective Actions of TGFβRI Inhibition Through Stimulating Autocrine/Paracrine of Survivin and Inhibiting Wnt in Cardiac progenitors. Stem Cells. 34:445–455. 2016. View Article : Google Scholar
51	Yeh CT, Yao CJ, Yan JL, Chuang SE and Lai GM, Chen CM, Yeh CF, Li CH and Lai GM: Apoptotic cell death and inhibition of Wnt/β-catenin signaling pathway in human colon cancer cells by an active fraction (HS7) from Taiwanofungus camphoratus. Evid Based Complement Alternat Med. 2011:7502302011. View Article : Google Scholar
52	Garg B, Giri B, Majumder K, Dudeja V, Banerjee S and Saluja A: Modulation of post-translational modifications in β-catenin and LRP6 inhibits Wnt signaling pathway in pancreatic cancer. Cancer Lett. 388:64–72. 2017. View Article : Google Scholar